Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Sarcoma 2Thrombocytopenia 1Solid Tumor, Childhood 1Osteosarcoma 1Neoplasms, Connective and Soft Tissue 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Healthy Volunteers 1Healthy Adults 1Congenital Abnormalities 1Bone Neoplasms 1

Interventions

Cytarabine 7Sorafenib 3Etoposide 3tipifarnib 2tanespimycin 2Mitoxantrone 2Idarubicin 2Filgrastim 2Cyclophosphamide 2Clofarabine 2Bortezomib 2Arsenic Trioxide 2romidepsin 1fludarabine phosphate 1entinostat 1eltrombopag 1alvocidib 1XK 469 1Vorinostat 1Thiotepa 1Radiotherapy 1Methoxsalen 1Imatinib Mesylate 1Ficusin 1Everolimus 1Decitabine 1Daunorubicin 1Cladribine 1Azacitidine 13-aminopyridine-2-carboxaldehyde thiosemicarbazone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Leukemia, Basophilic, Acute × eltrombopag × Clear all
NCT01550185 2022-07-22

Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia

Roswell Park Cancer Institute

Phase 1 Terminated
10 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡